(VIANEWS) – MFA Financial (MFA), Mueller Industries (MLI), ACADIA Pharmaceuticals (ACAD) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. MFA Financial (MFA)
44.7% sales growth and 5.14% return on equity
MFA Financial, Inc., together with its subsidiaries, operates as a real estate investment trust in the United States. The company invests in residential mortgage assets, including non-agency mortgage-backed securities, agency MBS, and credit risk transfer securities; residential whole loans, including purchased performing loans, purchased credit deteriorated, and non-performing loans; and mortgage servicing rights related assets. MFA Financial, Inc. was incorporated in 1997 and is based in New York, New York.
Earnings Per Share
As for profitability, MFA Financial has a trailing twelve months EPS of $0.63.
PE Ratio
MFA Financial has a trailing twelve months price to earnings ratio of 19.65. Meaning, the purchaser of the share is investing $19.65 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.14%.
Moving Average
MFA Financial’s value is above its 50-day moving average of $12.01 and above its 200-day moving average of $11.28.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter is 2.5% and a drop 18.4% for the next.
Revenue Growth
Year-on-year quarterly revenue growth grew by 499.9%, now sitting on 260.84M for the twelve trailing months.
Sales Growth
MFA Financial’s sales growth is 41.4% for the current quarter and 44.7% for the next.
2. Mueller Industries (MLI)
15.7% sales growth and 23.76% return on equity
Mueller Industries, Inc. manufactures and sells copper, brass, aluminum, and plastic products in the United States, the United Kingdom, Canada, South Korea, the Middle East, China, and Mexico. It operates through three segments: Piping Systems, Industrial Metals, and Climate. The Piping Systems segment offers copper tubes, fittings, line sets, and pipe nipples; PEX plumbing and radiant systems; and plumbing-related fittings and plastic injection tooling. It also resells steel pipes, brass and plastic plumbing valves, malleable iron fittings and faucets, and plumbing specialties; and supplies water tubes. This segment sells its products to wholesalers in the plumbing and refrigeration markets, distributors to the manufactured housing and recreational vehicle industries, building material retailers, and air-conditioning original equipment manufacturers (OEMs). The Industrial Metals segment manufactures brass, bronze, and copper alloy rods; plumbing brass, valves, fittings, and gas assemblies; cold-form aluminum and copper products; machining of aluminum, steel, brass, and cast iron impacts and castings; brass and aluminum forgings; brass, aluminum, and stainless-steel valves; fluid control solutions; and gas train assembles to OEMs in the industrial, construction, HVAC, plumbing, and refrigeration markets. The Climate segment offers valves, protection devices, and brass fittings for various OEMs in the commercial HVAC and refrigeration markets; high-pressure components and accessories for the air-conditioning and refrigeration markets; coaxial heat exchangers and twisted tubes for the HVAC, geothermal, refrigeration, swimming pool heat pump, marine, ice machine, commercial boiler, and heat reclamation markets; and insulated HVAC flexible duct systems. Mueller Industries, Inc. was founded in 1917 and is headquartered in Collierville, Tennessee.
Earnings Per Share
As for profitability, Mueller Industries has a trailing twelve months EPS of $4.83.
PE Ratio
Mueller Industries has a trailing twelve months price to earnings ratio of 15.11. Meaning, the purchaser of the share is investing $15.11 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 23.76%.
Yearly Top and Bottom Value
Mueller Industries’s stock is valued at $72.98 at 01:22 EST, below its 52-week high of $74.47 and way higher than its 52-week low of $34.96.
Volume
Today’s last reported volume for Mueller Industries is 633015 which is 18.17% below its average volume of 773587.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 12.8% and 6%, respectively.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Sep 6, 2024, the estimated forward annual dividend rate is 0.8 and the estimated forward annual dividend yield is 1.1%.
3. ACADIA Pharmaceuticals (ACAD)
10.6% sales growth and 6.7% return on equity
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization innovative medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases. It offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. The company also develops Trofinetide, a novel synthetic analog of the amino-terminal tripeptide of insulin-like growth factor 1 for treatment of Rett Syndrome; Pimavanserin that is in Phase III ADVANCE-2 study to treat the negative symptoms of schizophrenia; ACP-204 for the treatment of Alzheimer's disease psychosis; antisense oligonucleotide programs; and other programs for neuropsychiatric symptoms. It has a license agreement with Neuren Pharmaceuticals Limited to develop and commercialize trofinetide for Rett syndrome and other indications; and a license and collaboration agreement with Stoke Therapeutics, Inc. to discover, develop and commercialize novel RNA-based medicines for the potential treatment of severe and rare genetic neurodevelopmental diseases of the CNS. The company was formerly known as Receptor Technologies, Inc. and changed its name ACADIA Pharmaceuticals Inc. in 1997. The company was founded in 1993 and is headquartered in San Diego, California.
Earnings Per Share
As for profitability, ACADIA Pharmaceuticals has a trailing twelve months EPS of $0.19.
PE Ratio
ACADIA Pharmaceuticals has a trailing twelve months price to earnings ratio of 77.47. Meaning, the purchaser of the share is investing $77.47 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.7%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter is 135% and a drop 67.9% for the next.
Sales Growth
ACADIA Pharmaceuticals’s sales growth is 17.5% for the present quarter and 10.6% for the next.
Volume
Today’s last reported volume for ACADIA Pharmaceuticals is 1676880 which is 4.52% below its average volume of 1756400.
4. Main Street Capital Corporation (MAIN)
10.5% sales growth and 18.71% return on equity
Main Street Capital Corporation is a principal investment firm that primarily provides equity capital to lower middle market companies and debt capital to middle market companies. Main Street's portfolio investments are typically made to support management buyouts, recapitalizations, growth financings, refinancings and acquisitions of companies that operate in diverse industry sectors. Main Street seeks to partner with entrepreneurs, business owners and management teams and generally provides "one stop" financing alternatives within its lower middle market portfolio. Main Street's lower middle market companies generally have annual revenues between $10 million and $150 million. Main Street's middle market debt investments are made in businesses that are generally larger in size than its lower middle market portfolio companies.
Earnings Per Share
As for profitability, Main Street Capital Corporation has a trailing twelve months EPS of $5.36.
PE Ratio
Main Street Capital Corporation has a trailing twelve months price to earnings ratio of 9.34. Meaning, the purchaser of the share is investing $9.34 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.71%.
5. Red Rock Resorts (RRR)
9% sales growth and 187.95% return on equity
Red Rock Resorts, Inc., through its interest in Station Holdco and Station LLC, develops and operates casino and entertainment properties in the United States. It operates through two segments, Las Vegas Operations and Native American Management. The company owns and operates 9 gaming and entertainment facilities, and 10 smaller casinos in the Las Vegas regional market. In addition, it manages Graton Resort & Casino in northern California. As of December 31, 2021, it operated approximately 13,894 slot machines, 240 table games, and 3,081 hotel rooms in the Las Vegas market. The company was formerly known as Station Casinos Corp. and changed its name to Red Rock Resorts, Inc. in January 2016. Red Rock Resorts, Inc. was incorporated in 1976 and is based in Las Vegas, Nevada.
Earnings Per Share
As for profitability, Red Rock Resorts has a trailing twelve months EPS of $2.83.
PE Ratio
Red Rock Resorts has a trailing twelve months price to earnings ratio of 18.71. Meaning, the purchaser of the share is investing $18.71 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 187.95%.
Volume
Today’s last reported volume for Red Rock Resorts is 56177 which is 88.72% below its average volume of 498209.
Yearly Top and Bottom Value
Red Rock Resorts’s stock is valued at $52.95 at 01:22 EST, way below its 52-week high of $63.28 and way higher than its 52-week low of $37.82.
